LINACLOTIDE - Food and Drug Administration
- Set ID
- e398eb8a-37a1-aa89-6dd2-150ddfb47e9b
- Type
- Indexing - Product Concept
- Effective date
- 2014-05-08
- Version
- 1
- Source
- DailyMed source
Mapped DailyMed Labels#
Label, Relation, Manufacturer table| Label | Relation | Manufacturer | Effective |
|---|
| These highlights do not include all the information needed to use LINZESS safely and effectively. See full prescribing information for LINZESS . LINZESS ® ( linaclotide ) capsules, for oral use Initial U.S. Approval: 2012 | Product name | Allergan, Inc. | 2026-10-09 |
| These highlights do not include all the information needed to use LINZESS safely and effectively. See full prescribing information for LINZESS . LINZESS ® ( linaclotide ) capsules, for oral use Initial U.S. Approval: 2012 | Product name | Allergan, Inc. | 2026-05-21 |
| These highlights do not include all the information needed to use LINZESS safely and effectively. See full prescribing information for LINZESS . LINZESS ® ( linaclotide ) capsules, for oral use Initial U.S. Approval: 2012 | Product name | Allergan, Inc. | 2025-11-04 |
| These highlights do not include all the information needed to use LINZESS safely and effectively. See full prescribing information for LINZESS . LINZESS ® ( linaclotide ) capsules, for oral use Initial U.S. Approval: 2012 | Product name | Allergan, Inc. | 2025-11-04 |
| These highlights do not include all the information needed to use LINZESS safely and effectively. See full prescribing information for LINZESS . LINZESS ® ( linaclotide ) capsules, for oral use Initial U.S. Approval: 2012 | Product name | Allergan, Inc. | 2023-06-12 |